Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
May 23, 2024 02:00 ET
|
Burning Rock Biotech Limited
Burning Rock Schedules First Quarter of 2024 Earnings Release on May 29, 2024
[Latest] Global Non-Small-Cell Lung Cancer Drug Market Size/Share Worth USD 68,888.6 Million by 2033 at a 8.1% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 21, 2024 03:30 ET
|
Custom Market Insights
Austin, TX, USA, May 21, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Non-Small-Cell Lung Cancer Drug Market Size, Trends and Insights By Cancer Type...
[Latest] Global Colorectal Cancer Market Size/Share Worth USD 30,095.9 Million by 2033 at a 3.4% CAGR: Custom Market Insights (Analysis, Outlook, Leaders, Report, Trends, Forecast, Segmentation, Growth, Growth Rate, Value)
May 20, 2024 12:30 ET
|
Custom Market Insights
Austin, TX, USA, May 20, 2024 (GLOBE NEWSWIRE) -- Custom Market Insights has published a new research report titled “Colorectal Cancer Market Size, Trends and Insights By Type of Treatment (Surgery,...
AIM ImmunoTech to Participate in Two Upcoming Investor Conferences
May 20, 2024 09:15 ET
|
AIM ImmunoTech Inc.
OCALA, Fla., May 20, 2024 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today announced that AIM Chief Executive Officer Thomas K. Equels will participate in...
AgencyBloc Broadens User Conference Access to Industry
May 16, 2024 11:15 ET
|
AgencyBloc
AgencyBloc announces BlocBuilder 2025 conference will take place from April 13-15, 2025, at the Sheraton Grand at Wild Horse Pass. Pre-register now.
AIM ImmunoTech Reports First Quarter 2024 Financial Results and Provides Corporate Update
May 16, 2024 07:30 ET
|
AIM ImmunoTech Inc.
Continued execution across Ampligen® clinical development programs and growing body of positive data in multiple high-value indications Company to host conference call and webcast today, May...
Health Canada Approves Saladax’s 5-Fluorouracil Chemotherapy Therapeutic Drug Monitoring (TDM) Test
May 14, 2024 10:00 ET
|
Saladax Biomedical, Inc.
Bethlehem, PA, May 14, 2024 (GLOBE NEWSWIRE) -- Saladax Biomedical, Inc. (Saladax) is pleased to announce that Health Canada has approved Saladax’s 5-Fluorouracil (My5-FU) Assay for sale in Canada...
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
May 14, 2024 02:02 ET
|
Burning Rock Biotech Limited
Burning Rock Announces ADS Ratio Change to Be Effective on May 15, 2024
Turnstone Biologics Corp. Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
May 13, 2024 17:01 ET
|
Turnstone Biologics Corp.
Turnstone Biologics Reports First Quarter 2024 Financial Results and Provides Recent Business Highlights
Cardiff Oncology to Present at Upcoming Investor Conferences in May
May 13, 2024 16:05 ET
|
Cardiff Oncology, Inc.
SAN DIEGO, May 13, 2024 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition to develop novel therapies across a range of...